Trulicity 1.5 mg

Trulicity 1.5 mg contains Dulaglutide, a long-acting GLP-1 receptor agonist that mimics the action of natural hormones to stimulate insulin secretion, reduce glucagon release, and slow gastric emptying. This results in better blood sugar regulation, reduced post-meal glucose spikes, and decreased appetite.

It is prescribed for type 2 diabetes management in adults, particularly for those who require once-weekly injectable therapy to improve glycemic control and support weight management. Trulicity 1.5 mg can be used alone or in combination with other diabetes medications under medical supervision.

Key Benefits:

• Improves blood sugar control in type 2 diabetes

• Supports healthy weight loss and appetite management

• Reduces post-meal glucose spikes

• Long-acting weekly injection for convenience

• Clinically proven GLP-1 receptor agonist

Dosage & Administration:
Administer Trulicity 1.5 mg via subcutaneous injection once weekly, as prescribed by a healthcare provider. Dosage adjustments may be made based on glycemic response and tolerance.

Precautions:
Use only under medical supervision. Not suitable for individuals with a history of medullary thyroid carcinoma, pancreatitis, or hypersensitivity to Dulaglutide. Store in a refrigerator and protect from light.